Iterum Therapeutics PLC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
Iterum Therapeutics is offering non-transferable subscription rights to existing shareholders and eligible warrant holders to purchase up to 8,503,800 units, aiming to raise approximately $10.3 million.
Iterum Therapeutics is launching a rights offering to raise up to $10.3 million to fund its strategic process and support the review of its New Drug Application (NDA).
Iterum Therapeutics is launching a rights offering to raise up to $ million to fund its strategic process and support its NDA review.